With Congress poised to legislate new mandates for post-approval studies, it seemed like a good time to talk to Richard Gliklich, the president of Outcome and a professor of surgery at Harvard Medical School. We covered his company’s substantive conference on what happens after drugs are approved here. Gliklich’s take-away…more...

Johnson & Johnson selected ArisGlobal as its drug safety solution, a significant endorsement for the pharmacovigilance software house.  “With ArisGlobal’s ARISg robust feature set, flexible data model, intuitive user interface and ability to integrate with our key systems, Johnson & Johnson will incorporate this solution into our existing enterprise-wide processes,…more...

Tim Pratt cut his teeth in the world of medical devices, at Guidant and Medtronic, where a defibrillator can record 2,500 different variables. Fashioning a career out of working with such surging rivers of data, he landed at MedNet Solutions, where his title is chief marketing officer and principal scientific…more...

In a recent news brief about Omnicomm Systems, we noted that the electronic data capture company’s technology has been integrated with the with the NCI’s Center for Bioinformatics (NCICB) cancer Data Standards Repository (caDSR).  In checking in with Stephen Johnson, Omnicomm’s senior VP of business development, it’s clear the company…more...

Contract research organization (CRO) Kendle International (Nasdaq: KNDL) has chosen ClinPhone as its electronic data capture (EDC) vendor, and that comes as something of a surprise. Not because of ClinPhone, which is ramping up efforts to play in the most bruising tier of the EDC arena. What’s stunning is the…more...

The clinical trial technology suite etrials announced its financial results last week. “etrials remains at the forefront of bringing an integrated suite to an expanding market,” said president and CEO John Cline. The company says it has two new customers (with five projects between them) and a $20 million backlog…more...

Philadelphia’s Phoenix Data Systems (PDS), founded in 1997, has assisted on 400 clinical trials. It offers electronic data capture (EDC), interactive voice response (IVR) and electronic patient-reported outcomes (ePRO). In talking to the company over the years, we’ve always felt they were careful to avoid marketing hype.  A few weeks…more...

We’re wearing our flame-retardant pants today, just in case anyone sends an email our way. Wayne, Pennsylvania’s Octagon Research recently purchased Ninaza, a financially troubled electronic data capture (EDC) company in California. Ninaza had specialized in registries and post-approval trials. It’s an interesting acquisition for Octagon, with potentially far-reaching ramifications…more...

Major pharmaceutical companies continue to invest in Asia. Most recently Novartis announced that it is investing $100 million to build a state-of-the art drug development facility in China. Roche, Eli Lilly, AstraZeneca and other companies are already there. Performing clinical trials across the globe offers tremendous cost-savings opportunities to the…more...

Wyeth has been talking about the redesign of its approach and philosophy to clinical trials for years. As many readers know, the company restructured its drug discovery effort, and then tackled clinical—with some help from Accenture, which took over key tasks like data management in an open-books partnership. In that…more...